VALARY LAB PRIVATE LIMITED
VALARY LAB PRIVATE LIMITED (India) holds 21 active US FDA Type II Drug Master Files, has DMF or CEP filings on record for 19 active ingredients and is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “VALARY LAB PRIVATE LIMITED: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/valary-lab-private-limited
Overview
VALARY LAB PRIVATE LIMITED is an active pharmaceutical ingredient (API) supplier with 17 active FDA Type II Drug Master Files, covering BELZUTIFAN; BINIMETINIB; CABOZANTINIB MALATE (FORM-N2); DABRAFENIB MESYLATE; DESOGESTREL; ENCORAFENIB.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which VALARY LAB PRIVATE LIMITED holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
VALARY LAB PRIVATE LIMITED holds 21 active (21 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- AVAPRITINIB (FORM-A)Active2026-08-21
- TUCATINIB HEMIETHNOLATEActive2026-08-04
- AVAPRITINIBActive2026-06-19
- SELUMETINIB SULFATEActive2026-04-01
- DABRAFENIB MESYLATEActive2026-01-22
- DESOGESTRELActive2025-12-12
- RUXOLITINIB PHOSPHATEActive2025-07-25
- LEVONORGESTRELActive2025-07-18
- ENCORAFENIBActive2025-06-13
- BELZUTIFANActive2025-03-26
- RIBOCICLIB SUCCINATEActive2025-03-14
- ETHINYL ESTRADIOLActive2025-02-25
- CABOZANTINIB MALATE (FORM-N2)Active2025-01-03
- TIVOZANIB HYDROCHLORIDE MONOHYDRATEActive2024-12-12
- BINIMETINIBActive2024-11-27
- TRAMETINIB DIMETHYL SULFOXIDEActive2024-08-23
- PRALSETINIBActive2024-04-15
- NIRAPARIB TOSYLATE MONOHYDRATEActive2024-02-05
- LIOTHYRONINE SODIUMActive2023-09-29
- LENALIDOMIDE HEMIHYDRATE (FORM-B)Active2023-09-29
- LEVOTHYROXINE SODIUMActive2023-05-06
Registered manufacturing sites (1)
Physical sites registered with the US FDA and resolved to VALARY LAB PRIVATE LIMITED, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to VALARY LAB PRIVATE LIMITED in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this VALARY LAB PRIVATE LIMITED?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.